Harmony Biosciences appoints Peter Anastasiou as CEO
Harmony Biosciences (HRMY) announced Monday Peter Anastasiou has been appointed president, chief executive officer, and member of the Board of Directors, effective January 1, 2027.
The firm highlighted that he succeeds Jeffrey Dayno, who will retire as president and CEO and
KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.